Thomas Clare E, Storm Theresa A, Huang Zan, Kay Mark A
Department of Pediatrics, Stanford University School of Medicine, Stanford, California 94305, USA.
J Virol. 2004 Mar;78(6):3110-22. doi: 10.1128/jvi.78.6.3110-3122.2004.
Transduction of the liver with single-stranded adeno-associated virus serotype 2 (AAV2) vectors is inefficient; less than 10% of hepatocytes are permissive for stable transduction, and transgene expression is characterized by a lag phase of up to 6 weeks. AAV2-based vector genomes packaged inside AAV6 or AAV8 capsids can transduce the liver with higher efficiency, but the molecular mechanisms underlying this phenomenon have not been determined. We now show that the primary barrier to transduction of the liver with vectors based on AAV2 capsids is uncoating of vector genomes in the nucleus. The majority of AAV2 genomes persist as encapsidated single-stranded molecules within the nucleus for as long as 6 weeks after vector administration. Double-stranded vector genomes packaged inside AAV2 capsids are at least 50-fold more active than single-stranded counterparts, but these vectors also exhibit a lag phase before maximal gene expression. Vector genomes packaged inside AAV6 or AAV8 capsids do not persist as encapsidated molecules and are more biologically active than vector genomes packaged inside AAV2 capsids. Our data suggest that the rate of uncoating of vector genomes determines the ability of complementary plus and minus single-stranded genomes to anneal together and convert to stable, biologically active double-stranded molecular forms.
用单链2型腺相关病毒(AAV2)载体转导肝脏的效率较低;不到10%的肝细胞允许稳定转导,且转基因表达的特征是存在长达6周的延迟期。包装在AAV6或AAV8衣壳内的基于AAV2的载体基因组能够更高效地转导肝脏,但这一现象背后的分子机制尚未明确。我们现在表明,基于AAV2衣壳的载体转导肝脏的主要障碍是载体基因组在细胞核内的脱壳。在载体给药后长达6周的时间里,大多数AAV2基因组以核内包裹的单链分子形式持续存在。包装在AAV2衣壳内的双链载体基因组的活性至少比单链对应物高50倍,但这些载体在达到最大基因表达之前也表现出延迟期。包装在AAV6或AAV8衣壳内的载体基因组不会以包裹分子的形式持续存在,并且比包装在AAV2衣壳内的载体基因组具有更高的生物活性。我们的数据表明,载体基因组的脱壳速率决定了互补的正链和负链单链基因组退火在一起并转化为稳定的、具有生物活性的双链分子形式的能力。